Kangmei Pharma | 600518 - 流动资产



金融业
股票价格
CNY
资产
CNY 13.31B
现金及等价物
CNY 1.23B
销售成本
CNY 841.45M
流动资产
CNY 6.8B
流动负债
CNY 5.38B
债务
CNY 173.71M
EBIT
CNY -12.72M
EBITDA
CNY -12.72M
员工
6.37K
EPS每股收益
CNY 0
股本和储备
CNY 7.31B
销售毛利
CNY 238.34M
债务利息支出
CNY 1.82M
利息收入
CNY 2.44M
贷款资金
CNY 68.57M
市值
CNY 18.85B
净收入
CNY -16.56M
营业费用
CNY 1.09B
营业利润
CNY -10.94M
普通股股本
CNY 13.83B
PE价格收益
1.11K
税前利润
CNY -14.01M
销售收入
CNY 1.08B
销售和管理费用
CNY 237.06M
股票
CNY 2.38B
贸易债权人
CNY 2.46B
应收帐款人
CNY 2.92B


流动资产 更改 日
Akebia Therapeutics USD 229.55M 13.93M 2026-06
Alaunos Therapeutics USD 970K 1.02M 2026-03
Avita Medical AUD 35.49M 760K 2025-12
Cspc Pharmaceutical CNY 22.25B 359.48M 2025-12
Dianthus Therapeutics USD 897.54M 222.37M 2026-06
Genomma Lab Internacional MXN 13.19B 466.14M 2026-06
Hypermarcas BRL 6.71B 663.99M 2026-03
Ionis Pharmaceuticals USD 2.49B 446.73M 2026-06
IQVIA Holdings USD 6.23B 6M 2026-06
Jiangsu Hengrui CNY 49.61B 2.44B 2026-06
Kangmei Pharma CNY 6.8B 225.83M 2026-03
Moderna USD 5.82B 45M 2026-06
Organon & Co USD 5.11B 179M 2026-06
Revvity USD 2.3B 169.4M 2026-06
Sh Fosun Pharma CNY 33.96B 144.01M 2026-03
Tectonic Therapeutic USD 239.89M 17.47M 2026-03
Viatris USD 10.06B 861.1M 2026-06
Wuxi Apptec CNY 73.15B 7.98B 2026-06
Xeris Pharmaceuticals USD 274.76M 23.08M 2026-06
Zz Pientze Pharmaceu CNY 11.43B 728.95M 2026-03